These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22311386)

  • 21. Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population.
    Na R; Wu Y; Xu J; Jiang H; Ding Q
    PLoS One; 2013; 8(6):e67585. PubMed ID: 23825670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for using serum prostate-specific antigen (PSA) level and PSA density (PSAD) to detect prostatic malignancy in a country with low prostate cancer incidence.
    Rahardjo D; Kamil ST; Pakasi LS
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():563-70. PubMed ID: 10895211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of prostate specific antigen density and transrectal ultrasonography-guided biopsies in 100 consecutive patients with a negative digital rectal examination and intermediate serum prostate specific antigen levels.
    Tarcan T; Ozveri H; Biren T; Türkeri L; Akdas A
    Int J Urol; 1997 Jul; 4(4):362-7. PubMed ID: 9256325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml.
    Chang TH; Lin WR; Tsai WK; Chiang PK; Chen M; Tseng JS; Chiu AW
    BMC Urol; 2020 Oct; 20(1):151. PubMed ID: 33028274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
    Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
    Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection.
    Taneja SS; Tran K; Lepor H
    Urology; 2001 Aug; 58(2):222-7. PubMed ID: 11489705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the predictive accuracy of serum prostate specific antigen levels and prostate specific antigen density in the detection of prostate cancer in Hispanic-American and white men.
    Lam JS; Cheung YK; Benson MC; Goluboff ET
    J Urol; 2003 Aug; 170(2 Pt 1):451-6. PubMed ID: 12853797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.
    Akduman B; Alkibay T; Tuncel A; Bozkirli I
    Can J Urol; 2000 Oct; 7(5):1104-9. PubMed ID: 11114873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proprostate-specific antigen: its usefulness in the era of multiple-core prostate biopsy.
    Miyakubo M; Ito K; Yamamoto T; Takechi H; Ohi M; Suzuki K
    Int J Urol; 2009 Jun; 16(6):561-5. PubMed ID: 19456991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1).
    Chen R; Zhou LQ; Cai XB; Xie LP; Huang YR; He DL; Gao X; Xu CL; Ding Q; Wei Q; Yin CJ; Ren SC; Wang FB; Tian Y; Sun ZQ; Fu Q; Ma LL; Zheng JH; Ye ZQ; Ye DW; Xu DF; Hou JQ; Xu KX; Yuan JL; Gao X; Liu CX; Pan TJ; Sun YH;
    Asian J Androl; 2015; 17(6):1017-21. PubMed ID: 25926603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen velocity (PSAV) and PSAV per initial volume (PSAVD) for early detection of prostate cancer in Chinese men.
    Zheng XY; Zhang P; Xie LP; You QH; Cai BS; Qin J
    Asian Pac J Cancer Prev; 2012; 13(11):5529-33. PubMed ID: 23317212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with psa levels between 2.6 and 10.0 ng/mL.
    Castro HAS; Iared W; Santos JEM; Solha RS; Shigueoka DC; Ajzen SA
    Int Braz J Urol; 2018; 44(4):709-716. PubMed ID: 29697929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transition zone PSA density improves the prostate cancer detection rate both in PSA 4.0-10.0 and 10.1-20.0 ng/ml in Chinese men.
    Tang P; Du W; Xie K; Deng X; Fu J; Chen H; Yang W
    Urol Oncol; 2013 Aug; 31(6):744-8. PubMed ID: 21868261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate specific antigen adjusted for transition zone volume: the most powerful method for detecting prostate carcinoma.
    Kikuchi E; Nakashima J; Ishibashi M; Ohigashi T; Asakura H; Tachibana M; Murai M
    Cancer; 2000 Aug; 89(4):842-9. PubMed ID: 10951348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10-20 ng/mL and normal digital rectal examination.
    Chiu PK; Teoh JY; Lee WM; Yee CH; Chan ES; Hou SM; Ng CF
    Investig Clin Urol; 2016 Sep; 57(5):336-42. PubMed ID: 27617315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution.
    Nan LB; Yin XT; Gao JP
    Med Sci Monit; 2019 Nov; 25():8345-8351. PubMed ID: 31691648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of prostate cancer detection by prostate-specific antigen-related parameters.
    Egawa S; Suyama K; Takashima R; Mizoguchi H; Kuwao S; Baba S
    Int J Urol; 1999 Oct; 6(10):493-501. PubMed ID: 10533900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate specific antigen (PSA) value adjusted for transition zone volume and free PSA (gamma-seminoprotein)/PSA ratio in the diagnosis of prostate cancer in patients with intermediate PSA levels.
    Kurita Y; Terada H; Masuda H; Suzuki K; Fujita K
    Br J Urol; 1998 Aug; 82(2):224-30. PubMed ID: 9722757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of prostate specific antigen (PSA), PSA density, free-to-total PSA ratio and a new formula (prostate malignancy index) for detecting prostate cancer and preventing negative biopsies in patients with normal rectal examinations and intermediate PSA levels.
    Dinçel C; Caşkurlu T; Taşçi AI; Cek M; Sevin G; Fazlioğlu A
    Int Urol Nephrol; 1999; 31(4):497-509. PubMed ID: 10668945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is PSA density of the peripheral zone as a useful predictor for prostate cancer in patients with gray zone PSA levels?
    Lee J; Yang SW; Jin L; Lee CL; Lee JY; Shin JH; Lim JS; Song KH
    BMC Cancer; 2021 Apr; 21(1):472. PubMed ID: 33910525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.